Group 1 - The core point of the article is that Beixin Life (688712.SH) experienced a significant drop in stock price, closing at 41.84 yuan, a decrease of 6.67%, and hitting a new low since its listing [1] - Beixin Life was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on February 5, issuing 57 million shares, which accounts for 13.67% of the total share capital post-issuance, at a price of 17.52 yuan per share [1] - The total amount raised from the issuance was 998.64 million yuan, with a net amount of 898.89 million yuan after deducting issuance costs, which was 53.32 million yuan less than the original plan [1] Group 2 - The funds raised are intended for the construction of an interventional medical device industrialization base, research and development projects for interventional medical devices, and to supplement working capital [1] - The total issuance costs for Beixin Life's public offering amounted to 99.75 million yuan (excluding VAT), with underwriting and sponsorship fees accounting for 73.00 million yuan [1]
北芯生命上市第四个交易日跌6.67%创新低